VERPACKTES ARZNEIMITTEL MIT MERCAPTOCYCLODEXTRINDERIVAT ODER PHARMAZEUTISCH UNBEDENKLICHEM SALZ DAVON UND KONSERVIERUNGSVERFAHREN

European patent · EP4389103 · In force

Register entry

Publication number
EP4389103
Application number
EP22857911
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 19, 2022
Published
Jun 26, 2024
Granted
Jun 17, 2026
Protection ends at the latest
Aug 18, 2042
Next annual fee due
Aug 31, 2026
IPC classes
A61K 9/08 (2006.01)
A61K 9/00 (2006.01)
A61K 31/724 (2006.01)
A61P 21/02 (2006.01)
Priority
CN 202110952660 19.08.2021
PCT application
PCT/CN2022/113467 19.08.2022
PCT publication
WO2023/020602 23.02.2023
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 22, 2026

    Agent entered

    Representative
    DORMANN IP, RA Markus Dormann, Rosenweg 3, 3640 BAAR

    Published in Swissreg on 22.06.2026

  2. Jun 17, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.06.2026

Parties

Holder

Beijing Fresenius Kabi Pharmaceutical Co., Ltd.

F16 GrandyVic Building No.16 Taiyanggong Middle Street Chaoyang District, Beijing 100028, CN

Agent

DORMANN IP;RA Markus Dormann

DORMANN IP RA Markus Dormann

Rosenweg 3, 3640 BAAR

Inventor

XU, Wenjing

Wuhan, Hubei 430000, CN

LIU, Weitu

Wuhan, Hubei 430000, CN

ZHANG, Yongxia

Wuhan, Hubei 430000, CN

XIE, Ting

Wuhan, Hubei 430000, CN

ZHANG, Yijuan

Wuhan, Hubei 430000, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.